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Abstract
Background—Successful HIV treatment as prevention requires individuals to be tested, aware 
of their status, linked to and retained in care, and virally suppressed. Spatial analysis may be 
useful for monitoring HIV care by identifying geographic areas with poor outcomes.
Methods—Retrospective cohort of 1,704 people newly diagnosed with HIV identified from 
Philadelphia’s Enhanced HIV/AIDS Reporting System in 2008–2009, with follow-up to 2011. 
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Outcomes of interest were not linked to care, not linked to care within 90 days, not retained in 
care, and not virally suppressed. Spatial patterns were analyzed using K-functions to identify ‘hot 
spots’ for targeted intervention. Geographic components were included in regression analyses 
along with demographic factors to determine their impact on each outcome.
Results—Overall, 1,404 persons (82%) linked to care; 75% (1,059/1,404) linked within 90 days; 
37% (526/1,059) were retained in care; and 72% (379/526) achieved viral suppression. 59 census 
tracts were in ‘hot spots’, with no overlap between outcomes. Persons residing in geographic areas 
identified by the local K-function analyses were more likely to not link to care (AOR 1.76 [95% 
CI 1.30–2.40]), not link to care within 90 days (1.49, 1.12–1.99), not be retained in care (1.84, 
1.39–2.43), and not be virally suppressed (3.23, 1.87–5.59) than persons not residing in the 
identified areas.
Conclusion—This study is the first to identify spatial patterns as a strong independent predictor 
of linkage to care, retention in care, and viral suppression. Spatial analyses are a valuable tool for 
characterizing the HIV epidemic and treatment cascade.
INTRODUCTION
Early initiation of antiretroviral therapy (ART) for people living with HIV (PLWH) is 
beneficial to both the individual’s health and for reducing the likelihood of HIV 
transmission to others.1,2 Successful HIV treatment as prevention requires individuals to be 
tested, receive their test results, be linked and retained in care, initiate HIV therapy, and 
achieve viral load suppression. 3–5 Understanding the dynamics of this treatment cascade is 
essential to control HIV transmission on a community level. 3–5
Local and federal agencies have used surveillance data to evaluate the treatment cascade by 
age, sex, race/ethnicity, and HIV transmission risk.6–9 However, limited data exists on how 
geographic factors impact access to and retention in ARV treatment and suppression of viral 
load. Geographic information systems (GIS) technology allows for mapping and analyses 
able to identify geographic foci or hot spots, of disease, and have been effectively used to 
map the burden of tuberculosis, syphilis, and HIV infection in communities.10–12 In 
addition, GIS technologies have been used to analyze measures of proximity and access to 
resources.13–15 This methodology may also be useful for monitoring the HIV treatment 
cascade by identifying geographic areas with poor engagement in care and inadequate viral 
suppression.
As part of a Centers for AIDS Research (CFAR) supplement to support the Enhanced 
Comprehensive HIV Prevention and Planning (ECHPP) initiative, investigators from the 
Philadelphia Department of Public Health (PDPH) and the University of Pennsylvania 
(Penn) used GIS technologies to examine the current HIV treatment cascade (linkage to 
care, retention in care, and viral suppression) status for people originally diagnosed with 
HIV infection between 2008–2009 in Philadelphia, PA. To assist in public health planning 
of HIV care and case management services, we sought to identify geographic areas 
associated with not linking to care, not linking to care in 90 days, not retaining in care, and 
not achieving viral suppression after HIV diagnosis by comparing spatial patterns of a 
cohort of recently diagnosed cases.
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Data Source & Study Population
Data for analyses reported here were extracted from the City of Philadelphia’s Enhanced 
HIV/AIDS Reporting System (eHARS), a database containing information on all HIV cases 
reported to the PDPH AIDS Activities Coordinating Office (AACO) Surveillance Unit. 
Philadelphia has mandatory name-based case reporting of all new HIV infections in the 
City. Additionally, local mandates require reporting of all CD4 cell counts < 350/ml (or 
CD4 percent < 25%) and all HIV-1 RNA levels to the PDPH.16 Thus, eHARS contains 
records and laboratory results of all PLWH who were diagnosed with HIV in Philadelphia, 
were a resident of Philadelphia at any time after their HIV diagnosis, and all PLWH who 
received care in Philadelphia after their HIV diagnosis.
The eHARS database contains information collected through medical record abstraction 
including identifiers such as name, address, date of birth and address at diagnosis; as well as 
laboratory, pharmacy, and health service utilization information. Death data from the 
Pennsylvania Bureau of Vital Statistics, Social Security Death Master Index, and the 
National Death Index are routinely matched to eHARS data to identify deceased persons and 
document cause of death when available. The eHARS data are routinely monitored to 
identify duplicate cases and undergo quality control and verification to ensure that 
abstracted data are correctly assigned to unique case records.
As this study required assigning a spatial location to each person, individuals were included 
if they had a: (1) new HIV diagnosis date in 2008 or 2009, and (2) Philadelphia address at 
time of diagnosis. Those with invalid or insufficient address data and with prison addresses 
at time of diagnosis were excluded from analyses (N=157).
Predictor and Outcome Variables
For each person, we defined age, sex at birth, race/ethnicity, HIV transmission risk, and 
insurance status at the time of diagnosis. Age was divided into three groups: 13–24, 25–44, 
and ≥ 45 years old. Race/ethnicity was categorized as White, Non-Hispanic Black, Hispanic, 
or other. Transmission risk was grouped into heterosexual, men who had sex with men 
(MSM), injection drug use (IDU), and other/unknown. Patients who had IDU in 
combination with another risk factor (e.g. MSM, heterosexual transmission) were classified 
as IDU.
In addition, we collected information on imprisonment (dichotomously defined as one or 
more prison stay during the observation period); visits to multiple care sites (dichotomously 
defined as accessing two or more clinics during the observation period); and proximity to 
medical care (dichotomously defined as distance to the nearest care site less than the 
population average distance to the nearest care site). In Philadelphia, laboratory results are 
assigned a unique identifier indicating the facility associated with the requesting medical 
provider. This unique identifier was used to classify imprisoned patients and those accessing 
two or more clinics during the observation period.
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Outcomes of interest were based on four steps of the HIV treatment cascade and included: 1) 
not linked to care; 2) not linked to care within 90 days; 3) not retained in care; and 4) not 
achieving viral suppression. Linkage to care was defined as documentation of one or more 
CD4 or viral load test results after the date of diagnosis. Linkage to care within 90 days 
described patients with one or more CD4 or viral load test results in the 90 day period after 
diagnosis (calculated as the difference between date of diagnosis and date of first laboratory 
test). Retention in care was defined using the National Quality Forum Medical Visit 
Frequency Measure.17 This measure defines retention in care as completing at least one 
medical visit with a provider with prescribing privileges in each 6-month interval of the 24-
month measurement period, with a minimum of 60 days between medical visits. Date of first 
linkage to care defined the start of the 24-month measurement period. We used laboratory 
reports of CD4 and/or viral load testing as a proxy for HIV medical care visits. Prior studies 
have shown high correlation between laboratory test and medical visit data and retention in 
care.18 Viral suppression was classified as evidence of HIV-1 RNA < 200 copies/ml closest 
to the end of the 24-month measurement period ± 120 days.
Mapping and Spatial Analyses
Residential address data for persons meeting inclusion and exclusion criteria were imported 
to ArcGIS 9.3 for geocoding using ArcMap and address locator data provided by the PDPH 
Department of Technology (DOT). Persons were assigned spatial coordinates for subsequent 
analyses based on geographic location of residence at the time of diagnosis.
In its most straightforward application, the K-function provides an estimate of spatial 
dependence; and is based on all the distances between events in a given study area.19 This 
function compares the actual spatial location of points to a simulated random distribution of 
points using one or more distance bands. The value of the K-function determines whether a 
given point pattern is more clustered or dispersed than a point pattern of complete spatial 
randomness. Unlike other tests that examine variations in the intensity of phenomena over a 
given area, either by dividing an area into segments or calculating densities, the K-function 
is able to utilize multiple distance bands to detect clustering or dispersion at different scales. 
The ‘local’ K-function, which calculates a value at each point, rather than for the entire 
region, also identifies whether a point pattern is more clustered or dispersed; but, can 
additionally identify specific locations in the region (‘hot spots’ and/or ‘cool spots’) where 
the distribution of points differs significantly from the random distribution.20–22 The cross 
K-function utilizes a marked point process, and can be used to compare subgroups (e.g. 
persons linked versus not linked to care) of a single population to the distribution of all 
points in the region. This test can be used to compare points marked as ‘not linked to care’ 
with all points in the region to determine if the distributions are significantly different or 
spatially indistinguishable. 20–22 The local version of the cross K-function can identify 
specific locations in the region where points marked as ‘not linked to care’ are more 
clustered than all points in the region.
We used the local cross K-function to determine if: (1) the spatial patterns exhibited by 
persons that did not meet specific steps along the HIV treatment cascade differed 
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significantly from the overall pattern of people diagnosed with HIV; and if so, (2) where in 
the City those differences were observed.
The spatial location of each case was analyzed using three radial distance bands (1000, 2500 
and 5000 feet) to determine if points in marked pattern 1 (e.g. persons not linked to care) 
were significantly more clustered than points in marked pattern 2 (e.g. persons linked to 
care) for each of the four outcomes. Feet were used as the distance unit because the 
coordinates were calculated in feet. The primary distance radius of 5000 feet was selected 
based on one-half of the maximum distance between each point and its five nearest 
neighbors. The 5000 feet distance also encompasses the nearest neighbor distance for 99.9% 
of the cohort, and represents a rough approximation of one mile.
Cross K-function p-values were calculated using MATLAB and publicly available programs 
(designed by Tony E. Smith: http://www.seas.upenn.edu/~ese502/NOTEBOOK/Part_I/
5_Comparative_Analyses.pdf) to detect local variations of a marked point process. The p-
values at each spatial location were then imported to ArcMap and interpolated to a 
continuous raster surface file using the spline method in ArcToolbox. The interpolated 
surface raster was then converted to contour lines to highlight specific geographic areas 
where persons classified with negative outcomes along the HIV treatment cascade exhibited 
significant clustering compared to the full cohort of patients.
Our a priori hypothesis was that each step in the cascade is a distinct outcome with 
independent predictors that include both individual and community factors. As a result, the 
chosen denominator for each outcome was the numerator of the previous step in the cascade; 
all eligible diagnoses for linked to care, all persons linked to care for linked within 90 days 
and retention in care, and retained in care for viral suppression.
Statistical Analyses
Univariate statistics were used to describe the dataset. Multivariate logistic regression 
models were used to assess relationships between predictors and the outcomes. Models were 
adjusted for age, sex at birth, race/ethnicity, HIV transmission risk, and insurance status at 
the time of diagnosis; as well as imprisonment status, visits to multiple care sites, and 
proximity to nearest HIV medical provider. Additionally, we included geographic “hot spot” 
areas in the final model. To do this, contour hot spots were spatially joined to each person in 
order to assign a value indicating the distance between each person and the nearest contour. 
Persons were considered to be within the contour area if the calculated distance value was 
less than or equal to 5000 feet. Persons were assigned as either residing inside or outside of 
a particular area for each of the four outcomes. Adjusted odds ratios (AOR) with 95% 
confidence intervals (CI) are presented. Relationships were considered statistically 
significant at p<0.05.
RESULTS
Between 2008 and 2009, 1,861 people newly diagnosed with HIV were identified (Table 1). 
Of these, 157 (8%) had invalid address data or were imprisoned at time of diagnosis and 
were excluded from subsequent analyses. Excluded persons were less likely to be Black or 
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Hispanic; and more likely to be older adults, people with IDU as an HIV risk factor, and 
people with private insurance compared to included individuals. In addition, excluded 
patients were more likely to have had a prison stay during the subsequent observation 
period. Among the 1,704 persons included in the analyses, 70% were male, 63% were 
Black, and 30% were 45 years of age or older at time of diagnosis. The two most common 
HIV transmission risk factors were heterosexual (40%) and MSM (36%).
Overall, 1,404 persons (82% of 1,704) linked to care. Among those linked, 1,059 (75%) 
linked within 90 days and 526 (37%) were retained in care. Out of the 526 individuals 
retained in care, 379 (72%) achieved viral suppression. Correspondingly, 18%, 25%, 63%, 
and 28% of eligible individuals were not linked to care, not linked to care within 90 days, 
not retained in care, and not virally suppressed, respectively. (Table 2)
Geographic Patterns
As shown in Figure 1, Philadelphia is a city of neighborhoods bordered on the east by the 
Delaware River, which separates Pennsylvania and New Jersey, and to the north and west by 
three Pennsylvania counties: Montgomery, Delaware, and Bucks. The maps presented in 
Figure 2 show the geographic distribution of new HIV diagnoses (A1), HIV care sites (A2), 
and the areas identified as hot spots for each of the four outcomes (A3–A6). Overall, 12–19 
census tracts were included in the geographic clusters for each outcome, with a total of 59 
unique tracts (15.4% of all census tracts in Philadelphia).
New HIV cases tended to cluster in areas of high population including sections of North 
Philadelphia, Center City, South Philadelphia, and West Philadelphia. Geographic areas 
associated with not linking to care included North Philadelphia, as well as smaller segments 
of West Philadelphia and the Lower Northeast, and a long strip along the City’s western 
border with Montgomery County in the Roxborough section. Areas associated with not 
linking to care within 90 days include a small area of North Philadelphia, two small areas in 
West Philadelphia, and a long strip along the river in the Kensington section. Areas 
associated with not retaining in care are both more numerous and more geographically 
varied, including a large area in northern part of West Philadelphia near Fairmount Park, a 
smaller section in the neighborhood of West Philadelphia, an area at the southern end of 
South Philadelphia, a strip along the river in Center City, two sections of Oak Lane along 
the border with Montgomery County, and an area in the central section of the Lower 
Northeast. Three areas of the City were associated with not achieving viral suppression, 
including the Kensington section of North Philadelphia, a small area of Southwest 
Philadelphia, and the tip of Northwest Philadelphia in the Olney/Oak Lane neighborhood.
Multivariate Analyses
Logistic regression models were fit to evaluate the relationship between geographic hot 
spots (individually identified for each of the four steps evaluated in the HIV treatment 
cascade) and the outcomes of interest. (Table 3)
Model 1 – Not linked to care—Persons residing inside of the geographic areas identified 
by the local K-function analysis were more likely to not link to care compared to those 
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residing outside of these areas (AOR 1.76 [95% CI 1.30–2.40]). Additionally, Blacks (vs. 
whites), persons with IDU transmission risk (vs. heterosexual), and those with Medicare or 
no insurance (vs. private) had higher odds of non-linkage. Males were more likely to be not 
linked to care than females. No significant differences in linkage to care were detected 
between whites and Hispanics.
Model 2 – Not linked to care within 90 days—Among persons linked to care, 
individuals residing inside of the geographic areas identified by the local K-function 
analysis were more likely to not link to care within 90 days compared to those residing 
outside of these areas (AOR 1.49 [95% CI 1.12–1.99]). Compared to persons with private 
insurance, individuals with no insurance had higher odds of non-linkage within 90 days (i.e. 
less likely to link within 90 days). No differences were observed by sex, age, race/ethnicity, 
transmission risk, prison stay during the observation period or proximity to medical care 
sites.
Model 3 – Not retained in care—Among persons linked to care, individuals residing 
inside of the geographic areas identified by the local K-function analysis were more likely to 
not be retained in care compared to those residing outside of these areas (AOR 1.84 [95% CI 
1.39–2.43]). Blacks and Hispanics were more likely to be non-retained (i.e. less likely to be 
retained) than whites, while younger individuals were more likely to be non-retained 
compared to those older than 45 and older.
Model 4 – Not virally suppressed—Among all persons retained in care, those residing 
inside of the geographic areas identified by the local K-function analysis were more likely to 
not be virally suppressed compared to those residing inside of these areas (AOR 3.23 [95% 
CI 1.87–5.59). Persons whose nearest care site was more than the average distance to the 
nearest care site were more likely to not achieve viral suppression (i.e. less likely to be 
virally suppressed) compared to their counterparts who resided closer to their care sites. No 
differences were observed by sex, age, race/ethnicity, transmission risk, insurance, or prison 
stay during the observation period.
DISCUSSION
In this cohort, we identified 1,704 newly diagnosed persons with HIV who met inclusion 
criteria. Among these, 82% were linked to care; of whom 75% linked to care within 3 
months of diagnosis. Only 37% of patients linked to care were retained in care over 24 
months, and 72% of those who were retained in care achieved viral suppression. Overall, 
22% of persons recently diagnosed were linked to care, retained in care, and virally 
suppressed at the end of the follow-up period. This estimate is consistent with other 
published estimates of the treatment cascade and viral suppression in the United States.4 
Although predictors of failing to be linked to care, retained in care, and virally suppressed 
have been previously evaluated3,9,18,23–26, this study is unique in that it used community 
factors including geography and proximity to care as predictors.
Geographic clustering was independently associated with poor outcomes at each step along 
the HIV treatment cascade. We identified between 12 and 19 census tracts included in the 
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geographic clusters for each outcome, with a total of 59 unique tracts (15.4% of all census 
tracts in Philadelphia) across all outcomes. Interestingly, the geographic clusters identified 
for each step of the cascade were unique, with no geographic overlap between cascade steps. 
This suggests that the community-level factors responsible for worse outcomes may differ 
depending on the step of the HIV treatment cascade being evaluated.
Community factors related to poverty such as crime, housing stability, and poor access to 
transportation and social services may impact HIV treatment outcomes for individuals 
residing in geographic “hot spot” areas.27–29 We identified several characteristics 
differentiating these hot spots from the rest of the City of Philadelphia. First, hot spots for 
three of the four outcomes evaluated had narcotic arrest rates at least two times greater than 
the City average27. High narcotic arrest rates may indicate high drug use and crime in these 
communities. In addition, hot spots associated with not remaining in care had higher rates of 
aggravated assault compared to other parts of the City. Surprisingly, other markers of low 
socioeconomic status (poverty and education level) did not differ between hot spots and the 
remainder of the City. This finding may be limited by the high rate of poverty in 
Philadelphia overall, with nearly 45% of the general population living below 200% of the 
federal poverty level28. Of the ten largest cities in the US, Philadelphia has the highest rate 
of deep poverty, defined as people with incomes below half of the federal poverty level29. 
Evaluation of whether there are differences in the prevalence of deep poverty in these “hot 
spots” warrants further investigation.
Previous studies have shown that low neighborhood/community socioeconomic status is 
associated with a lower likelihood of having a usual source of health care, obtaining 
preventive services, and an increased likelihood of having unmet medical need, even after 
controlling for patient characteristics and supply of health care providers. 30 The impact of 
neighborhood environment and residents’ reaction to and perception of that environment has 
been linked to both risk of chronic disease and rates of self-management behaviors 
necessary for managing chronic disease. 31–34 Our study did not examine access to public 
transportation in these areas, access to social services or pharmacies, measures of social 
disorder such as crime and community response to crime, and community networks and 
norms (especially related to health and healthcare). We hypothesize that community norms 
and social disorder may have a greater effect on linkage to care; access to public 
transportation and social services may have a greater effect on retention in care; and access 
to pharmacies may have a greater effect on viral suppression. Differences in community 
factors that influence each step of the cascade may explain the lack of overlap in hot spots.
While, the 59 unique census tracts associated with the geographic “hotspot” areas represent 
14.5% of the population of Philadelphia, they represent 22.2% of all PLWH in the City. A 
higher burden of HIV disease in these communities with poor outcomes could indicate a 
need for additional services in these areas. However, proximity to HIV medical care site was 
not associated with linkage to care, linkage to care within 90 days, and retention in care, 
suggesting that inaccessibility to care is not the primary driver for the geographic clustering 
observed. Furthermore, our previous work on geography and access to HIV care in 
Philadelphia has shown that individuals do not tend to utilize HIV care at the facility nearest 
to their home residence35.
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Similar to prior studies, linkage to care, retention in care, and viral suppression rates differed 
for different socio-demographic groups18,25,26,31,32. After adjusting for geographic “hot 
spot” areas, IDU, heterosexuals, males, those with Medicare, and those without insurance 
were less likely to be linked to care. However, only those with no insurance coverage were 
less likely to link to care within 90 days. Our analysis of linkage to care differentiates 
between individuals who were ever linked to care from those who never linked to care (the 
denominator includes all people diagnosed with HIV). Whereas, our analysis of linkage to 
care within 90 days is in essence an evaluation of early versus late linkage to care; all 
persons in the denominator were those linked to care. Several prior studies examining 
predictors of delayed linkage to care did not identify any associations with demographic 
factors and mode of transmission, after persons who never linked to care were 
excluded. 38–40 One study; however, did find that persons of non-white race and IDU as 
mode of transmission were independently associated with delayed linkage, but the authors 
excluded persons with AIDS. 41 The exclusion of persons with AIDS may explain the 
associations with non-white race and IDU since these groups are more likely to present with 
AIDS than other demographic groups. Several studies have shown that the strongest 
predictor of delayed linkage to care is the type of setting in which an individual is tested and 
found to be HIV positive with non-medical sites, inpatient medical sites or while 
incarcerated being associated with delayed entry. 36, 40, 41 Our study did not look at the type 
of facility where the HIV diagnosis was made but this will certainly be a focus of future 
work.
Blacks and Hispanics were less likely to be retained in care, as were persons <25 years of 
age at the time of their HIV diagnosis. Persons who attended multiple clinics were more 
likely to meet the criteria for retention. Prior studies have demonstrated that patients 
utilizing multiple sites of care attend more outpatient visits compared to those receiving care 
at only one care site42. Proximity to care and geographic area were the only variables 
associated with viral suppression. Unlike prior studies that have identified disparities in rates 
of viral suppression for racial/ethnic minorities, we did not identify any demographic 
differences26,37,43. While further research is warranted, the lack of observed racial/ethnic 
disparities in viral suppression in our study may in part be explained by greater demographic 
similarity among those retained in care combined with a smaller sample size. Among those 
retained in care, environmental factors may be more salient predictors of treatment success.
Our study has several limitations that should be acknowledged. First, there were statistical 
differences in the demographic characteristics of age, mode of transmission, and insurance 
status between those in the cohort and those who were excluded. We believe the impact of 
these differences on our results is minimal because a high proportion of the potential cases 
(92%) were included in the analysis. Second, we excluded patients diagnosed while in the 
jail system. The incarcerated population represents a vulnerable population that should be 
studied independently. Their exclusion here was due to their diagnosis during incarceration 
which did not reflect the geographic predictors we intended to explore. Third, our findings 
come from routine HIV surveillance data; as such we could not assess ART coverage, may 
have incompletely accounted for migration out of Philadelphia among the patients in the 
cohort, and may have had underreporting of CD4 counts. Although, only CD4 results > 350 
cells/μL or > 25% of the total T-lymphocyte count were not reportable to the PDPH during 
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the cohort follow up period. All HIV viral loads were reportable as mandated by law, 
including those that were undetectable. Therefore, linkage to and retention in care would 
have been accurately ascertained by receipt of a viral load. Fourth, not all persons diagnosed 
with HIV during 2008 and 2009 would have been eligible for ART based on DHHS 
treatment guidelines during the follow up period, which may in part explain the lower than 
expected viral suppression rate. Fifth, we did not assess the impact of the density of general 
medical facilities, hospitals, and pharmacies, access to public transportation or other social 
services, and housing stability as a mechanism for the geographic clustering that we 
observed. Future studies should examine the impact of these community services on the HIV 
treatment cascade.
Lastly, our study cohort included individuals in a single large urban area who tested positive 
for HIV in one continuous 24 month period. Although the results may not be generalizable 
to other areas, the methods utilized for the spatial analyses could easily be replicated in other 
jurisdictions.
Our findings have very clear prevention implications. Previous studies have identified 
neighborhoods with high community viral loads as areas where uninfected individuals are at 
greater risk of acquiring HIV, compared to neighborhoods with lower community viral 
load.44–45 Measuring and utilizing community viral load is a goal of the National HIV/AIDS 
Strategy (NHAS) for the United States.46 NHAS also calls for innovative solutions for 
reducing community viral load that may help reduce the number of new HIV infections in 
specific communities. Our study is innovative in this regard, providing practical information 
on both when and where the breakdown in the care cascade occurs (which likely results in 
higher community viral load). Furthermore, the Centers for Disease Control and 
Prevention’s High Impact Prevention program calls for using combinations of scientifically 
proven, cost-effective and scalable interventions targeted to the right populations in the right 
geographic areas to increase the impact of HIV prevention efforts and meet the NHAS 
goals. 47 The methods used in our study can help identify the right populations (those not 
linked to care, not retained in care, and not virally suppressed) in the right geographic areas 
to scale-up scientifically proven, cost-effective interventions. We believe that a jurisdiction 
could specifically target separate linkage, retention and adherence interventions in the areas 
identified with the greatest need.
This study is the first to identify spatial patterns as a strong independent predictor of linkage 
to care, retention in care, and viral suppression. Moving forward, it will be important to 
assess other, ecological, community level and neighborhood infrastructure factors that may 
influence access to HIV medical care and treatment outcomes within the geographic clusters 
identified. Thus, spatial analyses are a valuable tool for characterizing the HIV epidemic and 
treatment cascade. Geographic-based tailoring of interventions to improve each aspect of the 
cascade will be critical to controlling the HIV epidemic in the United States.
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Table 1
Sample Characteristics of Persons Diagnosed with HIV in 2008 and 2009
Characteristics Included n=1,704 (%) Excluded n=157 (%) Chi Square Probability
Age at Diagnosis (years)
 < 25 398 (23.4) 24 (15.3) 7.06 0.03
 25–44 797 (46.8) 71 (45.2)
 45+ 509 (29.9) 59 (37.6)
 Unknown 3 (1.9)
Sex at Birth
 Female 509 (29.9) 39 (24.8) 1.40 0.24
 Male 1,195 (70.1) 115 (73.2)
 Unknown -- 3 (1.9)
Race/Ethnicity
 White 258 (15.1) 31 (19.7) 6.95 0.07
 Black 1,078 (63.3) 81 (51.6)
 Hispanic 293 (17.2) 11 (7.0)
 Other/Unknown 75 (4.4) 34 (21.7)
HIV Risk Factor
 Heterosexual 683 (40.1) 45 (28.7) 24.32 <0.0001
 MSM 619 (36.3) 51 (32.5)
 IDU 175 (10.3) 35 (22.3)
 Other/NIR 227 (13.3) 26 (16.6)
Insurance 26.77 <0.0001
 Private 338 (19.8) 19 (12.1)
 Medicaid 487 (28.6) 26 (16.6)
 Medicare 169 (9.9) 20 (12.7)
 Uninsured 285 (16.7) 26 (16.6)
 Other/Unknown 425 (24.9) 66 (42.0)
Prison Stay 0.39 0.53
 No 1,606 (94.2) 19 (12.1)
 Yes 98 (5.8) 150 (95.5)
Proximity to Care1
 No 742 (43.5) NA -- --
 Yes 962 (56.5)
1
Proximity to care indicates < average distance to nearest care site.
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